Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope

American Journal of Cardiovascular Drugs

Volumn 2, Issue 1, 2002, Pages 23-35

  Lamarre Cliche, Maxime ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CELECOXIB; CLONIDINE; DISOPYRAMIDE; ENALAPRIL; EPHEDRINE; ERGOTAMINE; FLUDROCORTISONE; FLUOXETINE; GLYCERYL TRINITRATE; IBUPROFEN; INDOMETACIN; METOCLOPRAMIDE; MIDODRINE; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OCTREOTIDE; PHENYLPROPANOLAMINE; PINDOLOL; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; RECOMBINANT ERYTHROPOIETIN; THREO 3,4 DIHYDROXYPHENYLSERINE; UNINDEXED DRUG; YOHIMBINE;

ABDOMINAL CRAMP; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE REGULATION; CLINICAL STUDY; CONTROLLED STUDY; DEPRESSION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG METABOLISM; DRUG POTENTIATION; DRUG TOLERABILITY; EDEMA; HEART FAILURE; HUMAN; HYPERTENSION; HYPOKALEMIA; INSOMNIA; ISCHEMIA; NAUSEA; NIGHTMARE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SEXUAL DYSFUNCTION; SYNCOPE; TACHYCARDIA; TREMOR;

EID: 0036249046     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200202010-00004     Document Type: Article

References (103)

1. Pathophysiology and differential diagnosis of neurocardiogenic syncope
2. The fainting patient: Value of the head-upright tilt-table test in adult patients with orthostatic intolerance
3. Neurocardiogenic syncope
4. Early effects of oral salt on plasma volume, orthostatic tolerance, and baroreceptor sensitivity in patients with syncope
5. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension
6. Haemodynamic analysis of efficacy of compression hosiery in elderly fallers with orthostatic hypotension
7. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone
8. Management of severe orthostatic hypotension by head-up-tilt posture and administration of fludrocortisone
9. Treatment of orthostatic hypotension: Interaction of pressor drugs and tilt table conditioning
10. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study
11. Role of physical countermaneuvers in the management of orthostatic hypotension: Efficacy and biofeedback augmentation
12. The North American Vasovagal Pacemaker Study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
13. Successful treatment of severe orthostatic hypotension with cardiac tachypacing in dual chamber pacemakers
14. Efficacy of different treatment strategies for neurocardiogenic syncope
15. The hypertension of autonomic failure and its treatment
16. Acute hemodynamic and humoral effects of metoclopramide on blood pressure control improvement in subjects with diabetic orthostatic hypotension
17. Drugs effective in the therapy of migraine
18. Treatment of chronic orthostatic hypotension with ergotamine
19. Effects of caffeine on blood pressure response during exercise in normotensive healthy young men
20. Midodrine: A review of its therapeutic use in the management of orthostatic hypotension
21. Hemodynamic effects of octreotide in patients with autonomic neuropathy
22. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension
23. Steady state pharmacokinetics and dose-proportionality of phenylpropanolamine in healthy subjects
24. Contrasting actions of pressor agents in severe autonomic failure
25. Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine
26. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: A randomized, double-blind multicenter study
27. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment
28. Phenylpropanolamine and the risk of hemorrhagic stroke
29. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: A randomized, placebo-controlled, crossover trial
30. Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase
31. Dopamine B hydroxylase deficiency responsible for severe dysautonomic orthostatic hypotension in an elderly patient
32. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension
33. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
34. Pressor responsiveness in corticosteroid-induced hypertension in humans
35. Mineralocorticoid induced hypertension and noradrenaline spillover in man
36. Therapeutic experience with fludrocortisone in diabetic postural hypotension
37. Shy-Drager syndrome: Effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flow
38. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)
39. Fludrocortisone in the treatment of hypotensive disorders in the elderly
40. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout
41. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure
42. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
43. The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin
44. Effects of indomethacin on postural hypotension in Parkinsonism
45. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin
46. Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors
47. Cardiovascular effects of fluoxetine in depressed patients with heart disease
48. E. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension
49. Fluoxetine in orthostatic hypotension of Parkinson's disease: A clinical and experimental pilot study
50. Treatment of orthostatic hypotension with dihydroergotamine and caffeine
51. Pressor effect of inhaled ergotamine in orthostatic hypotension
52. Ergotamine/caffeine treatment of orthostatic hypotension in parkinsonism with autonomic failure
53. Myocardial infarct during ergotamine medication in a young man with normal coronary arteries
54. Acute myocardial infarct after prophylactic administration of low doses of heparin-ergotamine: Coronary artery spasm the cause?
55. Vasospastic angina with angiographically normal coronary vessels of iatrogenic origin: Apropos of 2 cases
56. Effects of caffeine on vascular resistance, cardiac output and myocardial contractility in young men
57. Hemodynamic and humoral effects of caffeine in autonomic failure: Therapeutic implications for postprandial hypotension
58. The effect of caffeine on postprandial hypotension in the elderly
59. The frequency of caffeine withdrawal in a population-based survey and in a controlled, blinded pilot experiment
60. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin
61. Treatment of orthostatic hypotension with erythropoietin
62. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man
63. Treatment of orthostatic hypotension with midodrine and octreotide
64. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue, symptomatic and peptide responses
65. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion
66. Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995
67. Treatment of orthostatic hypotension with octreotide
68. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: A controlled study of acute administration
69. Lack of efficacy of octreotide in the long term treatment of orthostatic hypotension
70. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system
71. Oral yohimbine in human autonomic failure
72. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension
73. Metoclopramide alone or combined with flurbiprofen in the treatment of orthostatic hypotension associated with diabetes mellitus
74. Effect of metoclopramide on orthostatic hypotension in diabetes mellitus: Failure to demonstrate the role of vasoconstrictive hormones
75. Effects of beta adrenergic receptor agonists and antagonists in diabetics with symptoms of postural hypotension: A double-blind, placebo-controlled study
76. Hypertensive cardiovascular damage in patients with primary autonomic failure
77. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure
78. Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment
79. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
80. Absence of tachycardia during tilt test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope
81. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia
82. Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response
83. Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise
84. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope
85. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: Midodrine as second line treatment in patients refractory to beta-blockers
86. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope
87. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope
88. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results
89. Malignant vasovagal syncope: A randomised trial of metoprolol and clonidine
90. Predictors of tilting test negativization during beta-blocker treatment in patients with neurocardiogenic syncope
91. Yohimbine in neurally mediated syncope: Pathophysiological implications
92. Midodrine: A role in the management of neurocardiogenic syncope
93. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy
94. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope
95. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized, placebo-controlled trial
96. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: A randomized controlled trial
97. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents
98. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study
99. Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy
100. Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope
101. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt
102. The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope
103. Usefulness of transdermal scopolamine for vasovagal syncope